SOLARA ACTIVE PHARMA SCIENCES
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹36 Cr | ₹36 Cr | ₹36 Cr | ₹27 Cr | ₹26 Cr |
Equity - Authorised | ₹120 Cr | ₹120 Cr | ₹120 Cr | ₹120 Cr | ₹40 Cr |
Equity - Issued | ₹36 Cr | ₹36 Cr | ₹36 Cr | ₹27 Cr | ₹26 Cr |
Equity Paid Up | ₹36 Cr | ₹36 Cr | ₹36 Cr | ₹27 Cr | ₹26 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹1.05 Cr | ₹1.00 Cr | ₹3.79 Cr | ₹101 Cr | ₹106 Cr |
Total Reserves | ₹1,463 Cr | ₹1,488 Cr | ₹1,549 Cr | ₹958 Cr | ₹824 Cr |
Securities Premium | ₹1,216 Cr | ₹1,216 Cr | ₹1,212 Cr | ₹821 Cr | ₹781 Cr |
Capital Reserves | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Profit & Loss Account Balance | ₹249 Cr | ₹274 Cr | ₹339 Cr | ₹140 Cr | ₹45 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹-2.19 Cr | ₹-1.89 Cr | ₹-1.77 Cr | ₹-1.90 Cr | ₹-1.48 Cr |
Reserve excluding Revaluation Reserve | ₹1,463 Cr | ₹1,488 Cr | ₹1,549 Cr | ₹958 Cr | ₹824 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹1,500 Cr | ₹1,525 Cr | ₹1,589 Cr | ₹1,086 Cr | ₹956 Cr |
Minority Interest | ₹2.24 Cr | ₹2.31 Cr | ₹4.24 Cr | ₹4.29 Cr | ₹4.38 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹235 Cr | ₹283 Cr | ₹155 Cr | ₹233 Cr | ₹225 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹247 Cr | ₹369 Cr | ₹246 Cr | ₹353 Cr | ₹258 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-12 Cr | ₹-86 Cr | ₹-91 Cr | ₹-120 Cr | ₹-33 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-79 Cr | ₹-55 Cr | ₹-26 Cr | ₹12 Cr | ₹33 Cr |
Deferred Tax Assets | ₹162 Cr | ₹136 Cr | ₹108 Cr | ₹86 Cr | ₹54 Cr |
Deferred Tax Liability | ₹83 Cr | ₹81 Cr | ₹83 Cr | ₹98 Cr | ₹87 Cr |
Other Long Term Liabilities | ₹12 Cr | ₹34 Cr | ₹41 Cr | ₹56 Cr | ₹58 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹49 Cr | ₹37 Cr | ₹37 Cr | ₹33 Cr | ₹29 Cr |
Total Non-Current Liabilities | ₹217 Cr | ₹299 Cr | ₹206 Cr | ₹333 Cr | ₹344 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹306 Cr | ₹276 Cr | ₹309 Cr | ₹216 Cr | ₹244 Cr |
Sundry Creditors | ₹306 Cr | ₹276 Cr | ₹309 Cr | ₹216 Cr | ₹244 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹144 Cr | ₹174 Cr | ₹117 Cr | ₹157 Cr | ₹192 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹7.43 Cr | ₹17 Cr | ₹14 Cr | ₹20 Cr | ₹25 Cr |
Interest Accrued But Not Due | ₹2.20 Cr | ₹0.92 Cr | ₹0.48 Cr | ₹0.75 Cr | ₹0.49 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | ₹0.29 Cr |
Other Liabilities | ₹135 Cr | ₹156 Cr | ₹102 Cr | ₹137 Cr | ₹166 Cr |
Short Term Borrowings | ₹649 Cr | ₹610 Cr | ₹361 Cr | ₹354 Cr | ₹214 Cr |
Secured ST Loans repayable on Demands | ₹649 Cr | ₹610 Cr | ₹361 Cr | ₹354 Cr | ₹214 Cr |
Working Capital Loans- Sec | ₹649 Cr | ₹610 Cr | ₹361 Cr | ₹354 Cr | ₹214 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-649 Cr | ₹-610 Cr | ₹-361 Cr | ₹-354 Cr | ₹-214 Cr |
Short Term Provisions | ₹2.09 Cr | ₹3.77 Cr | ₹1.97 Cr | ₹2.70 Cr | ₹4.41 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.01 Cr | ₹0.33 Cr | ₹0.14 Cr | ₹0.84 Cr | ₹2.85 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹2.08 Cr | ₹3.44 Cr | ₹1.83 Cr | ₹1.86 Cr | ₹1.56 Cr |
Total Current Liabilities | ₹1,101 Cr | ₹1,063 Cr | ₹789 Cr | ₹730 Cr | ₹656 Cr |
Total Liabilities | ₹2,821 Cr | ₹2,890 Cr | ₹2,588 Cr | ₹2,153 Cr | ₹1,960 Cr |
ASSETS | |||||
Gross Block | ₹1,868 Cr | ₹1,760 Cr | ₹1,702 Cr | ₹1,611 Cr | ₹1,339 Cr |
Less: Accumulated Depreciation | ₹528 Cr | ₹429 Cr | ₹321 Cr | ₹214 Cr | ₹122 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1,340 Cr | ₹1,332 Cr | ₹1,382 Cr | ₹1,397 Cr | ₹1,218 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹238 Cr | ₹239 Cr | ₹88 Cr | ₹40 Cr | ₹40 Cr |
Non Current Investments | ₹1.70 Cr | ₹0.42 Cr | ₹0.42 Cr | ₹0.32 Cr | ₹0.41 Cr |
Long Term Investment | ₹1.70 Cr | ₹0.42 Cr | ₹0.42 Cr | ₹0.32 Cr | ₹0.41 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹1.70 Cr | ₹0.42 Cr | ₹0.42 Cr | ₹0.32 Cr | ₹0.41 Cr |
Long Term Loans & Advances | ₹29 Cr | ₹55 Cr | ₹59 Cr | ₹41 Cr | ₹36 Cr |
Other Non Current Assets | ₹0.51 Cr | ₹0.48 Cr | ₹1.17 Cr | ₹2.88 Cr | ₹17 Cr |
Total Non-Current Assets | ₹1,633 Cr | ₹1,651 Cr | ₹1,530 Cr | ₹1,481 Cr | ₹1,312 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹558 Cr | ₹576 Cr | ₹295 Cr | ₹280 Cr | ₹214 Cr |
Raw Materials | ₹119 Cr | ₹131 Cr | ₹110 Cr | ₹98 Cr | ₹87 Cr |
Work-in Progress | ₹275 Cr | ₹250 Cr | ₹148 Cr | ₹146 Cr | ₹100 Cr |
Finished Goods | ₹156 Cr | ₹188 Cr | ₹31 Cr | ₹31 Cr | ₹23 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹8.12 Cr | ₹6.63 Cr | ₹6.40 Cr | ₹5.28 Cr | ₹4.48 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹537 Cr | ₹490 Cr | ₹484 Cr | ₹227 Cr | ₹289 Cr |
Debtors more than Six months | ₹91 Cr | ₹34 Cr | ₹2.44 Cr | - | - |
Debtors Others | ₹462 Cr | ₹466 Cr | ₹483 Cr | ₹229 Cr | ₹291 Cr |
Cash and Bank | ₹8.89 Cr | ₹47 Cr | ₹199 Cr | ₹57 Cr | ₹76 Cr |
Cash in hand | ₹0.10 Cr | ₹0.04 Cr | ₹0.05 Cr | ₹0.10 Cr | ₹0.13 Cr |
Balances at Bank | ₹8.79 Cr | ₹47 Cr | ₹198 Cr | ₹57 Cr | ₹76 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹23 Cr | ₹18 Cr | ₹73 Cr | ₹40 Cr | ₹49 Cr |
Interest accrued on Investments | - | ₹1.38 Cr | ₹4.84 Cr | ₹0.23 Cr | ₹0.49 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.98 Cr | ₹1.17 Cr | - | ₹0.84 Cr | - |
Prepaid Expenses | ₹9.99 Cr | ₹8.41 Cr | ₹16 Cr | ₹7.32 Cr | ₹6.13 Cr |
Other current_assets | ₹12 Cr | ₹6.98 Cr | ₹52 Cr | ₹31 Cr | ₹43 Cr |
Short Term Loans and Advances | ₹60 Cr | ₹109 Cr | ₹7.32 Cr | ₹69 Cr | ₹20 Cr |
Advances recoverable in cash or in kind | ₹3.52 Cr | ₹4.97 Cr | ₹5.93 Cr | ₹17 Cr | ₹17 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹57 Cr | ₹104 Cr | ₹1.39 Cr | ₹52 Cr | ₹2.46 Cr |
Total Current Assets | ₹1,188 Cr | ₹1,239 Cr | ₹1,058 Cr | ₹672 Cr | ₹648 Cr |
Net Current Assets (Including Current Investments) | ₹86 Cr | ₹176 Cr | ₹269 Cr | ₹-58 Cr | ₹-7.40 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹2,821 Cr | ₹2,890 Cr | ₹2,588 Cr | ₹2,153 Cr | ₹1,960 Cr |
Contingent Liabilities | ₹3.61 Cr | ₹3.22 Cr | ₹6.22 Cr | ₹4.86 Cr | ₹6.19 Cr |
Total Debt | ₹1,001 Cr | ₹1,025 Cr | ₹607 Cr | ₹707 Cr | ₹538 Cr |
Book Value | 416.43 | 423.30 | 441.06 | 366.93 | 329.64 |
Adjusted Book Value | 416.43 | 423.30 | 441.06 | 366.93 | 329.64 |
Compare Balance Sheet of peers of SOLARA ACTIVE PHARMA SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOLARA ACTIVE PHARMA SCIENCES | ₹2,014.2 Cr | 1.5% | 46.2% | 50.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,831.0 Cr | -0.1% | -2.8% | 50.3% | Stock Analytics | |
CIPLA | ₹113,471.0 Cr | 4.5% | -3.1% | 52.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,713.0 Cr | 4.6% | 1.4% | 22.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,960.0 Cr | 4.7% | 10.8% | 18.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,687.8 Cr | 3.1% | -4.1% | 80.4% | Stock Analytics |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOLARA ACTIVE PHARMA SCIENCES | 1.5% |
46.2% |
50.2% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses